Dimension® Flex® reagent cartridge VALP 10444943Recalls & reported problems
Siemens Healthcare Diagnostics Inc. · Valproic Acid Flex® reagent cartridge, 80 tests · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00842768005718), received between Sep 6, 2017 and Sep 6, 2017 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Low Test Results” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Low Test Results3
Patient problems
- No Known Impact Or Consequence To Patient3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 6, 2017Low Test Results; Low Test Results
A DISCORDANT DEPRESSED VALPROIC ACID (VALP) RESULT WAS OBTAINED ON A PATIENT SAMPLE ON THE DIMENSION EXL SYSTEM. THE RESULT WAS REPORTED TO THE PHYSICIAN WHO QUESTIONED THE RESULT. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT DEPRESSED VALP RESULT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6845712 ↗MalfunctionSep 6, 2017Low Test Results; Low Test Results
A DISCORDANT DEPRESSED VALPROIC ACID (VALP) RESULT WAS OBTAINED ON A PATIENT SAMPLE ON THE DIMENSION EXL SYSTEM. THE RESULT WAS REPORTED TO THE PHYSICIAN WHO QUESTIONED THE RESULT. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT DEPRESSED VALP RESULT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6845705 ↗MalfunctionSep 6, 2017Low Test Results; Low Test Results
A DISCORDANT DEPRESSED VALPROIC ACID (VALP) RESULT WAS OBTAINED ON A PATIENT SAMPLE ON THE DIMENSION EXL SYSTEM. THE RESULT WAS REPORTED TO THE PHYSICIAN WHO QUESTIONED THE RESULT. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT DEPRESSED VALP RESULT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6845696 ↗
Other ENZYME IMMUNOASSAY, VALPROIC ACID devices
- VITROS 6801710Ortho-Clinical Diagnostics, Inc. · ENZYME IMMUNOASSAY, VALPROIC ACID1 recall23 reports
- Valproic Acid 4491041190Roche Diagnostics GmbH · ENZYME IMMUNOASSAY, VALPROIC ACID3 reports
- Atellica CH VPA 11097512Siemens Healthcare Diagnostics Inc. · ENZYME IMMUNOASSAY, VALPROIC ACID2 reports
- Valproic Acid 5108438190Roche Diagnostics GmbH · ENZYME IMMUNOASSAY, VALPROIC ACID2 reports
- Valproic Acid 20737933322Roche Diagnostics GmbH · ENZYME IMMUNOASSAY, VALPROIC ACID1 report
- IMMULITE® 2000 Systems VAL Valproic Acid 10381544Siemens Healthcare Diagnostics Products Ltd · ENZYME IMMUNOASSAY, VALPROIC ACID1 report
- Syva® Emit® 2000 Valproic Acid Assay 10445312Siemens Healthcare Diagnostics Inc. · ENZYME IMMUNOASSAY, VALPROIC ACID1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page